Salac, Marjorein .
HRN: 28-21-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFUROXIME 500MG (TAB)
12/06/2025
12/13/2025
PO
500
Bid
7 Days
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes